Topicus.com Inc. (TSXV:TOI) Releases Financial Results for Q4 and Year-End 2025

TORONTO, ON — February 25, 2026 — Leads & Copy — Topicus.com Inc. (TSXV:TOI), in conjunction with Constellation Software Inc. (TSX:CSU), has announced its financial results for the fourth quarter and year ended December 31, 2025.

The announcement, made Feb. 25, 2026, indicated that all figures are in Euros unless otherwise noted. The company has directed readers to view its annual consolidated financial statements and management’s discussion and analysis for a more comprehensive understanding of its financial standing.

Key financial highlights for Q4 2025 include:

Revenue: A 20% increase to €436.8 million, with organic growth accounting for 4% of this rise, compared to €364.9 million in Q4 2024.

Net Income: A 41% surge to €79.4 million (€0.59 diluted per share) from €56.2 million (€0.40 diluted per share) in Q4 2024.

Acquisitions: Completion of acquisitions for a total cash consideration of €49.9 million, which includes acquired cash. The estimated value of deferred payments associated with these acquisitions is €19.9 million, bringing the total consideration to €69.8 million. Topicus also completed a net investment in Asseco Poland S.A. amounting to €216.9 million.

Cash Flows from Operations: A 35% increase to €107.7 million, up from €79.6 million in Q4 2024.

Free Cash Flow Available to Shareholders (FCFA2S): A 40% increase to €51.2 million compared to €36.6 million in Q4 2024.

The financial highlights for the year 2025 include:

Revenue: Increased by 20% to €1,552.3 million (4% organic growth) compared to €1,294.9 million in 2024.

Net Income: Decreased by 53% to €70.1 million (€0.50 diluted per share) from €149.5 million (€1.11 diluted per share) in 2024.

Acquisitions: Completion of acquisitions for a total consideration of €390.4 million, including holdbacks and contingent consideration. The company also completed a net investment in Asseco Poland S.A. of €384.9 million.

Cash Flows from Operations: Increased by 19% to €412.7 million from €347.6 million in 2024.

Free Cash Flow Available to Shareholders (FCFA2S): Increased by 23% to €218.7 million compared to €177.4 million in 2024.

The company’s total revenue for the quarter ending December 31, 2025, reached €436.8 million, marking a 20% increase from €364.9 million in the same period of 2024. The total revenue for the year ending December 31, 2025, was €1,552.3 million, a 20% increase from €1,249.9 million in the prior year.

The net income for the quarter ending December 31, 2025, increased by €23.2 million to €79.4 million, compared to €56.2 million for the same period in 2024. This translates to a net income per basic and diluted share of €0.59, compared to €0.40 in 2024. However, the net income for the twelve months ending December 31, 2025, decreased by €79.4 million to €70.1 million, compared to €149.5 million in 2024. This results in a net income per basic and diluted share of €0.50, compared to €1.11 in the previous year.

For the quarter ended December 31, 2025, cash flows from operations increased €28.1 million to €107.7 million, compared to €79.6 million for the same period in 2024. For the twelve months ended December 31, 2025, cash flows from operations increased €65.0 million to €412.7 million, compared to €347.6 million for the same period in 2024.

For the quarter ended December 31, 2025, free cash flow available to shareholders increased €14.6 million to €51.2 million, compared to €36.6 million for the same period in 2024. For the twelve months ended December 31, 2025, free cash flow available to shareholders increased €41.3 million to €218.7 million, compared to €177.4 million for the same period in 2024.

Topicus.com Inc. acquires, manages, and builds vertical market software businesses. Topicus’ subordinate voting shares are listed on the Toronto Venture Stock Exchange under the symbol “TOI.”

Constellation Software Inc. acquires, manages, and builds vertical market software businesses. Constellation’s common shares are listed on the Toronto Stock Exchange under the symbol “CSU”.

Source: Topicus.com Inc.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.